FDA Gives in to Drug Manufacturer in Off-Label Marketing Suit
Last week the US Food and Drug Administration (FDA) lost another tooth, and the pharmaceutical industry won another battle in its ongoing effort to roll back safety regulations that impinge on its profit margin. The regulatory agency capitulated to drug company Pacira Pharmaceuticals’ demand that it revoke restrictions it had placed on Pacira’s marketing of